NEW YORK, NY / ACCESSWIRE / January 20, 2020 / The following statement is being issued by Levi & Korsinsky, LLP:
To: All Persons or Entities who purchased Neon Therapeutics, Inc. ("Neon" or the "Company") (NTGN) stock prior to January 16, 2020.
You are hereby notified that Levi & Korsinsky, LLP has commenced an investigation into the fairness of the sale of Neon to BioNTech SE ("BioNTech") (BNTX). Following consummation of the acquisition, Neon will merge with Endor Lights, Inc., a direct, wholly-owned subsidiary of BioNTech, and become a wholly-owned subsidiary of BioNTech. At closing, BioNTech will issue, and Neon shareholders will receive 0.063 American Depositary Shares (ADS) (each ADS representing one ordinary share of BioNTech) in exchange for each of their shares of Neon. To learn more about the action and your rights, go to:
or contact Joseph E. Levi, Esq. either via email at firstname.lastname@example.org or by telephone at (212) 363-7500. There is no cost or obligation to you.
The Neon merger investigation concerns whether the Board of Neon breached their fiduciary duties to stockholders by failing to adequately shop the Company before agreeing to enter into this transaction and whether BioNTech is underpaying for Neon shares, thus unlawfully harming Neon shareholders.
Levi & Korsinsky is a national firm with offices in New York, Connecticut, California, and Washington D.C. The firm's attorneys have extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities lawsuits and have recovered hundreds of millions of dollars for aggrieved shareholders. For more information, please feel free to contact any of the attorneys listed below. Attorney advertising. Prior results do not guarantee similar outcomes.
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
55 Broadway, 10th Floor
New York, NY 10006
Tel: (212) 363-7500
Fax: (212) 363-7171
SOURCE: Levi & Korsinsky, LLP
View source version on accesswire.com: